Area of focus

Controlled Substances and DEA

Regulatory and compliance issues concerning controlled substances require a nuanced perspective. 

We handle federal and state controlled substance regulatory issues from early pharmaceutical development through marketing including abuse liability assessment, scheduling, and compliance. 

We have practical...

Hogan Lovells Publications

U.S. House legislation highlights escalating government-wide focus on opioid abuse Pharmaceutical and Biotechnology Alert

On June 22 the U.S. House of Representatives passed sweeping legislation that represents "the biggest effort Congress has ever undertaken" to address the opioid epidemic, according to Rep....

Quick view Full view


Current issues in the distribution of controlled substances

Join us for a complimentary webinar on current issues affecting the distribution of controlled substances. In an efficient hour, we will provide an overview of the current state of play in...

Quick view Full view
Loading data